# Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders

> **NCT05792540** · PHASE2 · COMPLETED · sponsor: **Tanta University** · enrollment: 75 (actual)

## Conditions studied

- Depressive Disorder

## Interventions

- **DRUG:** Fluoxetine 20 mg
- **DRUG:** Dapagliflozin 10mg Tab
- **DRUG:** Atorvastatin 80mg

## Key facts

- **NCT ID:** NCT05792540
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-06
- **Primary completion:** 2024-11-20
- **Final completion:** 2024-12-20
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2025-01-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05792540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05792540, "Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05792540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*